About this trial
A total of 30 patients aged 18-65 years who present with chronic non-specific neck pain and 30 healthy volunteers will be included in the study. Patients with symptoms persisting for at least 3 months will be eligible for inclusion. Necessary information will be provided to all participants, and informed consent will be obtained.
To assess pain severity before treatment, participants will be asked to rate their complaints using the Visual Analog Scale (VAS), a linear scale for pain assessment. The Neck Disability Index will be used to determine the level of disability.
The Jaw Functional Limitation Scale-20 (JFLS-20), Patient Health Questionnaire-9 (PHQ-9), Patient Health Questionnaire-15: Physical Symptoms, Generalized Anxiety Disorder-7 (GAD-7), and the Oral Behaviors Checklist-included in Axis 2 of the DC/TMD form developed for evaluating temporomandibular joint dysfunction-will be used to assess patients' psychosocial characteristics and parafunctional habits.
Additionally, masseter muscle thickness will be evaluated using ultrasonographic measurement.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with chronic non-specific neck pain
Aged between 18-65 years
Symptoms persisting for at least 3 months
Disqualifiers
Pregnancy
Presence of psychiatric or neurological diseases
Use of psychiatric medications
Cognitive impairment
Trial population
The study population will consist of 30 patients diagnosed with chronic non-specific neck pain and 30 healthy volunteers, aged between 18 and 65 years.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Masseter Muscle Thickness
Measured using ultrasonography, with values interpreted in relation to clinical findings. No fixed score range; thickness is recorded in millimeters.
Secondary outcomes
Visual Analog Scale (VAS)
A linear scale used to assess pain severity, where higher scores indicate more severe pain. Score range: 0-10.
Neck Disability Index
A questionnaire used to evaluate the level of disability related to neck pain, with higher scores reflecting greater disability. Score range: 0-100.
Patient Health Questionnaire-9 (PHQ-9)
A scale measuring the severity of physical symptoms, where higher scores represent greater somatic symptom burden. Score range: 0-30.
Generalized Anxiety Disorder-7 (GAD-7)
A scale used to assess anxiety levels, with higher scores indicating more severe anxiety symptoms. Score range: 0-21.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.